NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002017

Registered date:15/06/2009

Evaluation of the Intraocular pressure lowering effect of Tafluprost and Latanoprost on normal tension Glaucoma

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedGlaucoma
Date of first enrollment2009/06/01
Target sample size30
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Tafluprost monotherapy of 12weeks, Latanoprost monotherapy of 12weeks and if possible, continue monotherapy with either ophthalmic solution for 52weeks Latanoprost monotherapy of 12weeks, Tafluprost monotherapy of 12weeks and if possible, continue monotherapy with either ophthalmic solution for 52weeks.

Outcome(s)

Primary OutcomeEfficacy: Intraocular Pressure Lowering rate
Secondary OutcomeSafety

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. Severe visual field defect (Ex:HFA <-15dB) 2. Any corneal abnormality or other condition preventing reliable applanation tonometry. 3. Presence of any external ocular disease, inflammation or infection of the eye and/or eyelids. 4. History of refractive surgery. 5. Diagnosed with degenerative miopia 6. History of laser trabeculoplasty, filtering surgery, trabeculotomy, or cataract surgery within 6 months. 7. Presence of any hypersensitivity to test drugs.

Related Information

Contact

public contact
Name Kazuhiko Mori, Morio Ueno, Yoko Ikeda
Address Japan
Telephone 075-251-5578
E-mail
Affiliation Kyoto Prefectural University of Medicine Department of ophthalmology
scientific contact
Name Kazuhiko Mori
Address Hirokoji Kawaramachi Kamigyo-ku Kyoto 602-0841 Japan
Telephone
E-mail
Affiliation Kyoto Prefectural University of Medicine Department of ophthalmology